Reichler, Mary R.
Hirsch, Christina
Yuan, Yan
Khan, Awal
Dorman, Susan E.
Schluger, Neil
Sterling, Timothy R.
Bakhtawar, I.
LeDoux, C.
McAuley, J.
Beison, J.
Fitzgerald, M.
Naus, M.
Nakajima, M.
Schluger, N.
Hirsch-Moverman, Y.
Moran, J.
Blumberg, H.
Tapia, J.
Singha, L.
Hershfeld, E.
Roche, B.
Mangura, B.
Sevilla, A.
Sterling, T.
Chavez-Lindell, T.
Maruri, F.
Dorman, S.
Cronin, W.
Munk, E.
Khan, A.
Yuan, Y.
Chen, B.
Yan, F.
Shen, Y.
Zhao, H.
Zhang, H.
Bessler, P.
Fagley, M.
Reichler, M.
Sterling, T.
Tapia, J.
Hirsch, C.
Luo, C.
,
Funding for this research was provided by:
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (200-2001/0002)
Article History
Received: 26 August 2019
Accepted: 22 June 2020
First Online: 31 July 2020
Ethics approval and consent to participate
: The protocol was approved by the institutional review boards at the Centers for Disease Control and Prevention (FWA00001413), Case Western Reserve University (FWA00004428), Columbia University (FWA00002636), Emory University (FWA0005792), Vanderbilt University (FWA00005756), New Jersey Department of Health (FWA00004020), Rush University (FWA00000482), University of Arkansas (FWA00002205), and Maryland Department of Health (FWA00002813), and by the research ethics boards of the University of British Columbia (FWA00000668) and the University of Manitoba (FWA00002049). Participants were enrolled using written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.